In this study, Song et al. reveal the physiological roles for enteroendocrine cells (EEs) and gut hormones in intestinal lipid metabolism regulation in Drosophila. They demonstrate that tachykinin (TK) EEs regulate intestinal lipid production and systemic lipid homeostasis via production of gut TK hormones and modulation of lipogenesis in enterocytes.
In Brief
In this study, Song et al. reveal the physiological roles for enteroendocrine cells (EEs) and gut hormones in intestinal lipid metabolism regulation in Drosophila. They demonstrate that tachykinin (TK) EEs regulate intestinal lipid production and systemic lipid homeostasis via production of gut TK hormones and modulation of lipogenesis in enterocytes.
INTRODUCTION
Under normal feeding conditions, lipids digested from dietary food are absorbed by enterocytes (ECs) and resynthesized into triglyceride (TG) and packaged into lipoprotein particles that are transported to peripheral tissues for energy supply (Warnakula et al., 2011) . Defects in enteric lipid homeostasis have been implicated in obesity, type 2 diabetes, and cardiovascular diseases (Anzai et al., 2009; Warnakula et al., 2011) . Thus, characterization of the molecular mechanisms that coordinate lipid uptake, synthesis, and mobilization with lipid homeostasis in the intestine is critical for understanding the basis of lipid metabolic disorders.
Gut hormones secreted from enteroendocrine cells (EEs) play crucial roles in systemic lipid homeostasis, such as the control of appetite and lipid metabolism in peripheral tissues. For example, cholecystokinin (CCK) from I cells, EEs in the mucosal epithelium of the small intestine, reduces food intake through CCK1 receptors on the vagal nerve (Sullivan et al., 2007) . Ghrelin from B/D1 cells that are mainly located in the stomach and duodenum reduces lipid mobilization in adipose tissues (Tschö p et al., 2000) . Interestingly, glucagon-like peptide-1 (GLP1) secreted from L cells in the ileum and colon suppresses intestinal chylomicron release and postprandial plasma TG levels (Qin et al., 2005) , whereas glucagon-like peptide-2 (GLP2), cosecreted with GLP1, stimulates free fatty acid uptake in the intestine and increases plasma TG levels (Hsieh et al., 2009) , suggesting that modulation of intestinal lipid metabolism is another important physiological role of gut hormones in maintaining systemic lipid homeostasis. However, probably due to gene redundancy and overlapping functions, loss-of-function studies in the mouse for gut hormones and their receptors have failed to associate them with severe metabolic changes (Mellitzer and Gradwohl, 2011) . Thus, how these hormones coordinate lipid metabolism in the intestine is still not clear.
In recent years, Drosophila has emerged as a powerful genetic system to study intestinal homeostasis. Although it is simpler than the mammalian gastrointestinal tract, the Drosophila gut is similar at both the cellular and molecular levels (Apidianakis and Rahme, 2011) . In particular, the adult midgut contains EEs, marked by the transcription factor Prospero (Pros), that express nine major gut prohormones, allatostatin A (AstA), AstB, AstC, neuropeptide F (NPF), short NPF, tachykinin (TK), diuretic hormone 31 (DH31), and CCHamides 1 and 2, which are processed into over 24 mature peptides (Reiher et al., 2011) . Previous studies have documented their expression patterns. For example, TK, the most abundant one, is expressed in the anterior, middle, and posterior midgut and encodes six mature peptides (TK1-TK6; Poels et al., 2009; Siviter et al., 2000; Veenstra, 2009; Veenstra et al., 2008) . Only in a few cases have the gutspecific functions of these hormones been reported. In vitro treatments have shown that TK1-TK5 can stimulate gut contraction (Siviter et al., 2000) , and loss of DH31 EEs or gut hormones in the larval midgut result in impaired peristalsis (LaJeunesse et al., 2010) . Other than these examples, the physiological roles of EE hormones in gut lipid metabolism are completely unknown.
In order to analyze the physiological functions of gut hormones, we first characterized a specific Gal4 driver that is expressed in TK EEs. Using this Gal4 driver, we demonstrate that TKs produced by midgut EEs regulate intestinal lipid metabolism by controlling lipid synthesis in ECs.
RESULTS

Identification of a Gal4 Driver Specifically Targeting TK EEs
Because TKs are expressed both in the CNS and midgut (Asahina et al., 2014; Birse et al., 2011; Reiher et al., 2011; Winther et al., 2006) , we first characterized a Gal4 driver that would allow us to perform genetic manipulation in gut TK EEs only. We screened several TK-Gal4 transgenic lines (see Experimental Procedures) and identified one of them, referred to as ''TK-gutGal4 (TKg-Gal4),'' as driving gene expression solely in TK EEs, but not TK neurons ( Figures 1A and 1B) . EEs differ from intestinal stem cells (ISCs) and are present in pairs between two ECs ( Figures 1C-1E ). TK EEs, which exist as one of the heterologous pairs of EEs ( Figures 1C and 1D ), are numerous in the anterior, mid, and posterior midgut and have a characteristic shape, simultaneously contacting both hemolymph and the gut lumen ( Figure 1F ). Additionally, TK EEs also produce NPF in the middle midgut and DH31 in the middle-posterior midgut (Figures 1G and 1H; Veenstra et al., 2008) .
TKs Derived from TK EEs Control Intestinal Lipid Metabolism
To study the physiological role of TK gut hormones, we selectively ablated TK EEs by expressing the apoptotic gene reaper (RPR) under the control of TKg-Gal4. Compared to controls that showed strong TK expression in both the gut and brain (TKg>Con), TK expression was lost only in the gut of TKg>RPR1 flies (Figures 2A and 2B ). TK EE ablation also significantly decreased Pros-positive EE number and impaired the paired appearance of EEs in the midgut ( Figure S1A ). Consistent with TK EE depletion, NPF and DH31 mRNAs and proteins of TKg>RPR1 flies were dramatically reduced in the gut but remained at normal levels in the CNS (Figures S1B and S1C) . However, ablation of TK EEs did not result in significant gut contraction/emptiness defects as analyzed using the blue-dye food assay but was associated with a slight increase in body weight and a slight decrease in food intake (Figures S1D-S1F).
Specific ablation of TK EEs allowed us to examine whether gut peptides affect intestinal lipid metabolism. In wild-type animals, intestinal TG level, the major form of neutral lipid, accounts for only about 1% of the total body TG content ( Figure S1G ), reflecting the role of the intestine in lipid transport. Moreover, neutral lipid droplets, detected with the neutral lipid Bodipy dye, are most abundant in the ECs located in the anterior and posterior regions of the adult midgut (Figures S1H, S1I, S3D, and S3E). Strikingly, in the absence of TK EEs, we observed a dramatic increase of neutral lipid level in midgut ECs (Figures 2C and S3D ; compare to TKg>Con control). As midgut lipids are transported throughout the body as energy supplies (Palm et al., 2012; Thummel, 2009, 2012) , elevation of the intestinal lipid level may be due to an increase in lipid production in the midgut, a decrease in lipid transport, or both. To address this question, we measured the levels of circulating TG in the hemolymph. TKg>RPR1 flies showed a 50% increase in TG levels in hemolymph ( Figure 2D ). Furthermore, whole-body TG ( Figure 2E ) and neutral lipid levels in the fat body ( Figure S3D ), a major lipid storage organ, in TKg>RPR1 were dramatically increased, suggesting that TK EE ablation increases intestinal lipid production and promotes systemic lipid distribution.
To confirm that the elevated lipid production in midgut was due to a deficiency in gut hormones from TK EEs, we suppressed gut hormone process and maturation by knocking down the expression of the proprotein convertase amontillado (AMON) (Reiher et al., 2011) . Similar to TK EE ablation, AMON knockdown, which has been shown to diminish mature TK production in TK EEs (Reiher et al., 2011) , led to increased lipid levels in gut and whole body ( Figures 2C and 2E) . Further, to identify the hormone(s) involved in lipid metabolic regulation, we knocked down the expression of each of the three gut hormones, TK, NPF, and DH31, in TK EEs ( Figures 2B and S1J ). Surprisingly, only TK knockdown (TKg>TK-i) resulted in an increase of intestinal lipid production, hemolymph TG level, and TG storage ( Figures 2C-2E and S3D ). Taken together, our observations indicate that TK gut hormones, but not NPF or DH31, regulate intestinal lipid metabolism and subsequently affect systemic lipid storage.
Brain-and Gut-Derived TKs Play Distinct Physiological Roles
We wondered whether TKs produced from the gut or CNS regulate similar processes. Thus, we compared the phenotypes associated with TK knockdown only in the gut versus both in the brain and gut. RNAi against TK driven by ELAV-Gal4 (ELAV>TK-i) diminished TK expression in both the gut and CNS compared to control flies (ELAV>white-i; Figures S2A and S2B). These flies showed increased locomotor activity and reduced olfactory responses to certain chemicals ( Figures  S2C and S2D ) as previously reported (Ignell et al., 2009; Winther et al., 2006) . However, TK knockdown only in the gut failed to affect locomotor activity or the olfactory response ( Figures  S2C and S2D ). Additionally, unlike the effect observed when brain TKs were depleted (Birse et al., 2011) , we did not detect a change in Drosophila insulin-like peptide 2 (dILP2) content in insulin-producing cells or body weight ( Figures S2E-S2G ) when TKs were knocked down only in the gut. These data demonstrate that gut TKs specifically regulate intestinal lipid metabolism and that they are not involved in behavior regulation or secretion of dILPs, functions attributable to TK neuropeptides.
TKR99D/PKA Regulates Lipid Metabolism in ECs in
Response to Gut TKs To determine how TK regulates lipid production in ECs, we tested whether removal of the TK receptor affects intestinal lipid metabolism. Two different G-protein-coupled TK receptors expressed in gut, TKR99D and TKR86C, have been identified (Birse et al., 2006; Poels et al., 2009) . Interestingly, whereas TKR86C is mainly expressed in gut muscles and a few EEs (Poels et al., 2009) , TKR99D, as determined using a TKR99D-Gal4 line, appears highly expressed in lipid absorptive ECs ( Figure 3A) , as well as in a few TK/NPF EEs ( Figures S3A and S3B) . Strikingly, knockdown of TKR99D in ECs by about 60% ( Figures  3B and S3C ) was sufficient to result in an increase in midgut lipid production and whole-body TG storage (compare Myo1A>TKR99D-i to Myo1A>Con; Figures 3D, 3E, and S3E) .
To test whether gut TKs or TKR99D regulate enteric lipid metabolism through G protein-coupled receptor (GPCR)/cyclic AMP (cAMP)/protein kinase A (PKA) signaling as previously suggested (Birse et al., 2006; Lundquist and Nä ssel, 1997) , we tested the activity of cAMP response element-binding protein (CREB), a direct substrate of PKA, using a CRE-Luciferase reporter (Belvin et al., 1999) . TK knockdown (TKg>TKi) dramatically decreased CREB transcriptional activity in ECs compared to control (TKg>white-i), whereas activation of PKA by feeding flies with forskolin, a PKA agonist, restored CREB transcriptional activity to a normal level ( Figure 3C ). Furthermore, overexpression of a catalytic form of PKA in ECs (Myo1A > PKA, TKR99D-i) was sufficient to reverse the increased intestinal lipid production and systemic TG storage ( Figures 3D and 3E ) associated with TKR99D knockdown. Collectively, our results suggest that gut TKs regulate EC lipid metabolism through TKR99D/PKA signaling.
TKs Suppress Lipogenesis in the Midgut
To identify the lipid-processing pathways regulated by TKs in ECs, we analyzed the mRNA expression profile of genes involved in intestinal lipid metabolism. Interestingly, the intestinal lipases Magro (Sieber and Thummel, 2009 ) and CG2772, which regulate dietary lipid digestion in the gut lumen, and the two key enzymes of lipogenesis fatty acid synthase (FAS) and acetyl-coenzyme A carboxylase (ACC), which control enteric lipid synthesis (Lim et al., 2011) , were all upregulated when TK production was reduced (TKg > TK-i; Figure S3F ), suggesting that TKs regulate intestinal lipid metabolism via multiple lipid-processing pathways. On the other hand, expression of the lipid transporter NinaD involved in lipid absorption (Kiefer et al., 2002) , the ER unfolded protein response sensor IRE1 and microsomal triglyceride transfer protein, which regulate lipoprotein particle packaging (Iqbal et al., 2008) , and the intestinal lipase CG31089 that controls dietary lipid digestion remained unaffected (Figure S3F) . Notably, mRNA expression of the FoxO target genes 4E binding protein (4EBP) and insulin receptor (InR) in the midgut were not affected by removal of TKs ( Figure S3F ), suggesting that gut TKs do not affect insulin signaling in the midgut.
The upregulation of FAS induced by TK deficiency ( Figures 4A  and S3F ) suggested that TKs regulate midgut lipid metabolism, at the least, by modulation of intestinal lipogenesis. To test this hypothesis, flies were fed with 14 C-labeled glucose, and the lipids derived from 14 C-carbon backbones in the gut were measured. TK>TK-i flies contained more lipids derived from glucose carbon backbones in the midgut ( Figure 4C ), suggesting that TK deficiency promotes midgut lipogenesis. Sterol regulatory element-binding protein (SREBP) is a conserved transcription factor for lipogenic genes, like FAS ( Figure 4B ; Kunte et al., 2006) and is negatively modulated by GPCR/cAMP/PKA signaling (Lu and Shyy, 2006) . Consistent with this idea, TKR99D/PKA signaling in ECs suppressed FAS expression and lipogenesis in the midgut (Figures 4B and 4C ).
Intestinal Lipogenesis Contributes to TK DeficiencyInduced Midgut Lipid Production and Systemic Lipid Storage
To test whether intestinal lipogenesis is sufficient to contribute to changes in midgut lipid production, we expressed an active form of SREBP in ECs (Myo1A>SREBP). As predicted, increases of midgut FAS mRNA expression, intestinal lipid production, and whole-body TG storage were observed in Myo1A>SREBP flies ( Figures 4B, 4D , and 4E). Conversely, specific SREBP knockdown in ECs (Myo1A>SREBP-i) decreased midgut FAS expression and body TG storage ( Figures 4B and 4G) . Thus, intestinal lipogenesis is essential for midgut lipid production and systemic lipid storage. We further tested whether SREBPinduced lipogenesis is required for TKs regulation of intestinal lipid metabolism. Surprisingly, SREBP knockdown in ECs potently blocked the increase of midgut lipid level and systemic TG storage associated with TKR99D knockdown ( Figures  4F and 4G) . Collectively, our results indicate that gut TKs regulate intestinal lipid metabolism through, at least, repression of SREBP-induced lipogenesis.
The Midgut Produces TKs in
Response to Nutrient Availability Release or production of gut hormones is regulated by diverse physiological conditions in different species. An increase of TKs released from gut into the hemolymph has been observed in the starved locust (Winther and Nä ssel, 2001 ). Thus, we tested whether TK levels in the gut are affected by starvation. Flies deprived of food for 24 hr showed a significant increase in TK levels in their midgut ( Figure S4A ). To test whether increased intracellular TK levels were due to less TK secretion or more TK production, the expression of downstream targets of TK signaling in the midgut were measured. Strikingly, TK/PKAdependent CREB activity was potently increased (Figure S4B ), whereas FAS mRNA suppressed by TK signaling was dramatically decreased ( Figure S4C ), suggesting that starvation enhances TK production in the midgut. Consistent with this idea, diminishing intestinal TK expression partially restored midgut FAS expression and lipid production under starvation ( Figures  S4C and S4D) . To determine which nutrient regulates TK production, flies were refed with different ingredients after starvation, such as sucrose, coconut oil, or yeast. Interestingly, only yeast refeeding potently suppressed TK production in midgut ( Figure S4E ). As amino acids are the major nutrient in yeast, our results suggest that the midgut produces TKs in response to amino acid availability.
To examine whether nutrient status or TKR99D signaling changes in ECs regulate TK production in a feedback manner, we specifically modulated TKR99D signaling in ECs. Knockdown of TKR99D or overexpression of PKA in ECs showed altered lipid levels ( Figures 3D and 3E ) but did not affect TK levels in midgut EEs ( Figure S4F ), suggesting that TK signaling or lipid levels in ECs do not regulate intestinal TK production.
Interestingly, in contrast to mammalian regulation of TK production by infection with a gut pathogen, flies fed with the human pathogen Pseudomonas aeruginosa 14, previously shown to cause severe gut defects and gut stem cell proliferation in Drosophila (Apidianakis et al., 2009 ), failed to show any change in intracellular TK levels ( Figure S4G ). These results suggest that the presence of pathogen does not affect production of gut TKs in Drosophila.
DISCUSSION
Previous studies in mammals have indicated that a few gut secretory hormones, like GLP1 and GLP2, are involved in intestinal lipid metabolism (Qin et al., 2005) . However, due to gene and functional redundancy, mammalian genetic models for gut hormones and/or their receptors with severe metabolic defects are not available. Here, we establish that Drosophila TKs produced from EEs coordinate midgut lipid metabolic processes. Our studies clarify the roles of TK hormones in intestinal lipogenesis and establish Drosophila as a genetic model to study the regulation of lipid metabolism by gut hormones.
Six mature TKs, TK1-TK6, are processed and secreted from TK EEs in both the brain and midgut (Reiher et al., 2011) . Using a specific Gal4 driver line, we were able to specifically manipulate gene expression in TK EEs, leading us to demonstrate that loss of gut TKs results in an increase in midgut lipid production. Further, we showed that TKs regulate intestinal lipid metabolism associated with TKR99D, but not TKR86C, which is consistent with the expression of these receptors. Consistent with previous reports that TK/TKR99D signaling regulates cAMP level and PKA activation (Birse et al., 2006; Lundquist and Nä ssel, 1997) , loss of gut TKs is associated with a reduction in PKA activity in ECs, and overexpression of a PKA catalytic subunit was able to reverse the increased intestinal lipid production associated with loss of TKR99D. In addition, the transcription factor SREBP that triggers lipogenesis was controlled by TK/TKR99D/PKA signaling. Taken together, our results suggest that TKs produced from EEs regulate midgut lipid metabolism via TKR99D/PKA signaling and regulation of, at least, SREBP-induced lipogenesis in ECs.
Interestingly, our study reveals that TKs derived from either the brain or gut exhibit distinct functions: TKs derived from gut control intestinal lipid metabolism, whereas TKs derived from brain control behavior. This is reminiscent of the distinct functions of mammalian secreted regulatory peptides, where different spatial expressions or deliveries of peptides like Ghrelin can result in distinct physiological functions (Nakazato et al., 2001; Tschö p et al., 2000) . In addition, some prohormones encode multiple mature peptides that can have multiple functions. For example, processing of proglucagon in the pancreas a cells preferentially gives rise to glucagon, which antagonizes the effect of insulin. In intestine L cells, however, proglucagon is mostly processed into GLP1 to promote insulin release (Brubaker and Drucker, 2004) . Our studies of TKs exemplify how secreted regulatory peptides derived from different tissues can be associated with fundamentally diverse physiological functions. Clearly, additional studies examining the function of secreted peptides in a cell-type-and tissue-specific manner are needed to fully appreciate and unravel their complex roles both in flies and mammals.
There is a growing body of studies emphasizing that intestinal lipid metabolism is key to the control of systemic lipid homeostasis. For example, chemicals such as orlistat (Heck et al., 2000) , designed to inhibit dietary lipid digestion/absorption in the intestine, efficiently reduce obesity. In addition, mammalian inositol-requiring enzyme 1b deficiency-induced abnormal chylomicron assembly in the small intestine results in hyperlipidemia (Iqbal et al., 2008) . Similarly, in Drosophila, dysfunction of intestinal lipid digestion/absorption caused by Magro/LipA deficiency eventually decreases whole-body lipid storage and starvation resistance (Karpac et al., 2013; Thummel, 2009, 2012) . Further, intestinal lipid transport, controlled by lipoproteins, is essential for systemic lipid distribution and energy supply in other tissues (Palm et al., 2012; Paná ková et al., 2005) . Consistent with these observations, we demonstrate that increased midgut lipid synthesis associated with gut TK deficiency is sufficient to elevate systemic lipid storage. Although TK ligands and TK receptors show high homologies between mammals and fruit flies (Birse et al., 2006) , whether mammalian TK signaling plays a similar role in intestinal lipid metabolism is largely unknown. Future studies will reveal whether mammalian TK signaling affects intestinal lipid metabolism as in Drosophila. If this is the case, it may provide a therapeutic opportunity for the treatment of intestinal lipid metabolic disorder and obesity.
Production and secretion of gut hormones are precisely regulated under various physiological conditions. Similar to previous observations that starvation induces gut TK secretion in other insects (Winther and Nä ssel, 2001 ), we found that nutrient deprivation promotes TK production in EEs. Interestingly, feeding of amino-acid-enriched yeast, but not coconut oil or sucrose, potently suppressed gut TK levels, indicating that amino acids may act directly on TK production in EEs. It has been reported that dietary nutrients regulate gut hormone production through certain receptors located on the cell membrane of EEs in mammals (Reimann et al., 2012) . Future studies will be necessary to elucidate the detailed mechanism by which nutrients regulate TK production from EEs.
EXPERIMENTAL PROCEDURES
Drosophila Strains
Expression patterns of different TK-Gal4 P-element lines that contain the 0.5-2.5 kb fragment upstream of the TK gene were examined by crossing to UASsrcGFP flies. One line that showed expression in TK EEs, but not in TK neurons, was referred to as TK-gut-Gal4 (TKg-Gal4) and used for this study. Other lines were obtained from Bloomington Drosophila Stock Center, TRiP at Harvard Medical School, and Vienna Drosophila Resource Center. See the Supplemental Experimental Procedures for detailed information.
Immunostaining and Western Blot
Immunostaining of adult midgut and brain and western blot were described previously (Karpowicz et al., 2010; Song et al., 2010) . See the Supplemental Experimental Procedures for detailed information.
TG Measurement
TG measurement was performed as previously described (Song et al., 2010) . See the Supplemental Experimental Procedures for detailed information.
qRT-PCR Quantitative RT-PCR (qRT-PCR) was performed as previously described (Song et al., 2010) . See the Supplemental Experimental Procedures for detailed primer information.
Midgut Lipogenesis Measurement
Adult flies were fed with 0.2 mCi/ml 14 C-glucose (PerkinElmer) for 3 days.
Thirty guts were dissected and homogenized in 200 ml of chloroform/methanol/water (2:1:1) mixture. The lysate was incubated at 37 C for 1 hr before 75 ml chloroform and 75 ml 1 M KCl were added. After centrifugation at 3,000 rpm for 2 min, 14 C-labeled lipids in the chloroform phase were measured by liquid scintillation counting.
Behavior Assays
Behavior assays were performed as previously described (Winther et al., 2006) .
Statistical Analyses
The data are presented as the mean ± SEM. Student's t tests were used for comparisons between two groups. p < 0.05 was considered statistically significant. 
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